title: Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
abstract: The use of GnRH antagonist rather than agonist cotreatment during ovarian hyperstimulation for IVF is not widely accepted. Possible benefits, current shortcomings, and avenues for future development are discussed.
authors.forename: Bart C J M
authors.initials: BC
authors.lastname: Fauser
authors.forename: Paul
authors.initials: P
authors.lastname: Devroey
mesh_terms: D001294:Attitude to Health; D005260:Female; D005307:Fertilization in Vitro / Q000009:adverse effects / Q000379:methods*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000037:antagonists & inhibitors*; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy* / Q000209:etiology
chemical_list: D006727:Hormone Antagonists; D007987:Gonadotropin-Releasing Hormone